ARROWHEAD PHARMACEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Arrowhead Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$171M, a 65.9% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$539M, a 197% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$205M, a 16.6% decline from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$176M, a 25% decline from 2021.
  • Arrowhead Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$141M, a 66.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$205M -$29.2M -16.6% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-29
2022 -$176M -$35.2M -25% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-29
2021 -$141M -$56.3M -66.6% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-29
2020 -$84.6M -$153M -224% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-28
2019 $68M +$122M Oct 1, 2018 Sep 30, 2019 10-K 2021-11-22
2018 -$54.5M -$20.1M -58.4% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-23
2017 -$34.4M +$47.3M +57.9% Oct 1, 2016 Sep 30, 2017 10-K 2019-11-25
2016 -$81.7M +$10.2M +11.1% Oct 1, 2015 Sep 30, 2016 10-K 2016-12-14
2015 -$91.9M -$33.3M -56.8% Oct 1, 2014 Sep 30, 2015 10-K 2016-12-14
2014 -$58.6M -$27.5M -88.3% Oct 1, 2013 Sep 30, 2014 10-K 2016-12-14
2013 -$31.1M -$10M -47.4% Oct 1, 2012 Sep 30, 2013 10-K 2015-12-14
2012 -$21.1M -$18M -575% Oct 1, 2011 Sep 30, 2012 10-K 2014-11-25
2011 -$3.13M +$2.65M +45.8% Oct 1, 2010 Sep 30, 2011 10-K 2012-12-28
2010 -$5.77M Oct 1, 2009 Sep 30, 2010 10-K 2011-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.